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Cardiovascular diseases are the most common cause of 
death in North America and Europe [1] killing more 
than 860,000 people annually in the United States [2, 3]. 
Moreover, 80 million people in the USA are estimated 
to suffer from cardiovascular diseases [2, 3]. Known or 
associated causes of cardiovascular disease include 
diabetes mellitus, smoking, high cholesterol, hyper-
tension,   inflammation,   overweight   and  obesity,  or  
 
 











































physical inactivity [2, 3]. Although there have been 
great advances in the understanding of heart failure in 
recent decades [4] and acute treatment of heart attacks 
has markedly improved survival, one essential key issue 
is how to potentially regenerate the heart after injury. 
 
It had been assumed that cardiac regeneration is 
impossible; however, cardiac progenitor cells have been 
found at low frequency even in the mammalian heart 
and major attempts have been made to either use the 




















Abstract: Cardiac  remodeling  and  subsequent  heart  failure  remain  critical  issues  after  myocardial  infarction  despite
improved  treatment and  reperfusion  strategies. Recently, complete cardiac  regeneration has been demonstrated  in  fish
and newborn mice following resection of the cardiac apex. However, it remained entirely unclear whether the mammalian
heart can also completely regenerate following a complex cardiac  ischemic  injury. We established a protocol to  induce a
severe  heart  attack  in  one‐day‐old  mice  using  left  anterior  descending  artery  (LAD)  ligation.  LAD  ligation  triggered
substantial  cardiac  injury  in  the  left ventricle defined by Caspase 3 activation and massive cell death.  Ischemia‐induced
cardiomyocyte death was also visible on day 4 after LAD  ligation. Remarkably, 7 days after the  initial  ischemic  insult, we
observed complete cardiac regeneration without any signs of tissue damage or scarring. This tissue regeneration translated
into  long‐term  normal  heart  functions  as  assessed  by  echocardiography.  In  contrast,  LAD  ligations  in  7‐day‐old  mice
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potential of progenitor cells for cardiac repair [5, 6] or 
to transdifferentiate cardiac stroma cells into cardio-
myocytes [7, 8]. Pioneering experiments demonstrated 
that fish can completely regenerate the heart following 
resection of the heart apex [9], a finding that has 
spurned multiple studies using fish as a model organism 
[10-14]. Intriguingly, it has also been recently shown 
that newborn mice, but not mice beyond one week of 
age, can regenerate the cardiac apex following resection 
[15]. However, it remained entirely unclear whether 
mammals can regenerate the heart following a complex 
cardiac ischemic injury that affects central cardiac 
regions of the heart, is associated with massive cell 
death and tissue damage.  
 
Here we report the development of a cardiac ischemia 
injury model in newborn mice. Intriguingly, despite 
massive tissue damage in this model, we observed 





































indicating that heart regeneration is possible following 




A novel model system for irreversible cardiac injury 
in newborn mice 
 
To examine whether there is cardiac regeneration in 
newborn mammalian heart following a complex 
ischemic injury, i.e. myocardial infarction, we 
established a protocol for left anterior descending artery 
(LAD) ligation in one-day-old mice, i.e. postpartum 
P0.5 to postpartum P1.5 (Fig. 1A). Using hypothermia 
anesthesia [16], the LAD artery was irreversibly ligated 
and subsequent tissue remodeling and regeneration were 
assessed using serial histological sectioning of the 
hearts combined with immunohistochemistry and 






































open  the  chest  cavity and  irreversibly  ligate  the  left anterior descending artery  (LAD)  in newborn mice. Representative  images are
shown.  In Sham‐operated mice the chest cavity was opened, without LAD  ligation.  (B‐D) Massive cardiac damage 24 hours after the
initial LAD ligation as demonstrated by H&E staining (B), immune‐detection of cleaved Caspase 3 (cC3) (B), loss of TroponinT expression
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LAD ligation on P0.5 resulted in massive tissue 
damage determined 24 hours after the initial injury as 
assessed by histological damage, Caspase 3 activation 
(cleaved caspase 3) to assess cell death (Fig. 1B), and 
Troponin T staining as a measure of cardiomyocyte 
damage (Fig. 1C). Moreover, echocardiography at 24 
hours after injury revealed markedly altered left 
ventricular end-diastolic diameters (LVEDD) and left 
ventricular end-systolic diameters (LVESD) resulting 
in massive impairment in fractional shorting (Fig. 1D), 
a measure for cardiac function [17]. Thus, LAD 
ligation in newborn mice results in massive cardiac 











































Complete cardiac regeneration following massive 
cardiac infarction in newborn mice 
 
We next followed the time course of cardiac tissue 
damage. Four days following initial LAD ligation in 
newborn mice, we still observed marked tissue injury. 
Remarkably, starting around day 7 we observed nearly 
complete cardiac regeneration. On the consecutive days 
of analysis (P12.5, P16.5, and P21.5) we also did not 
observe any histological sign of residual tissue damage 
(Fig. 2A). Moreover, echocardiography of 3 months old 
mice that where ligated on P0.5 showed complete and 
long-term restoration of cardiac functions as compared 











































































To determine the time window for cardiac 
regeneration following LAD ligation, we performed 
cardiac infarction experiments in mice at P1.5 and at 
P7.5 after birth; heart regeneration was determined on 
day P28.5. Whereas complete regeneration was 
observed when the left anterior descending artery was 
ligated in newborn mice, the ischemic damage could 
not be repaired when LAD ligation was performed in 
7.5 day-old mice (Fig. 3). Thus, newborn mice have 
the capacity for complete morphological as well as 
functional cardiac regeneration following massive 
ischemic heart damage and this capacity is lost by day 
7.5 of age.  
 
Cell fate mapping of regenerating cardiomyocytes 
 
Staining for TroponinT to image loss of cardiomyocytes 
and for the proliferation marker Ki67 showed marked 
proliferation of cells in the infarction zone on P4.5 of 
mice that were LAD-ligated shortly after birth (P0.5) 
(Fig. 4A). This finding was confirmed using phospho-
H3 immunostaining. Importantly, we observed 
phospho-H3 staining in TroponinT positive cardio-
myocytes at this time point indicating that 
cardiomyocytes at the edge of the infarction zone had 
entered the cell cycle (Fig. 4B). BrdU labeling further 
confirmed that at P7.5 the TroponinT+ cardiomyocytes 
that were present in the regenerated initial infarction 
zone had undergone DNA replication (Fig. 4C,D). 
Thus, the infarction zone is repopulated by cardio-

























To trace the lineage of the regenerated cardiomyocytes 
that have repaired the ischemic injury area, i.e. already 
differentiated cardiomyocytes that can enter the cell 
cycle and thus repair the injury vs recruitment of 
progenitor cells [6], we performed lineages tracing 
experiments using two mouse lines (Fig. 5A). This 
genetic set-up allowed us to induce, via Tamoxifen, 
YFP expression in cardiomyocytes and thereby follow 
their fate in the injury zone, a model system previously 
used to mark cardiomyocyte fate [15, 18]. In order to 
extend the time-window between the tamoxifen 
administration and LAD ligation we injected tamoxifen 
into pregnant mothers at E19.5. This strategy led to a 
reduced but constant labeling efficiency of about 40%. 
In the neonates we then ligated the LAD and harvested 
the hearts 7 days later on P8.5 (Fig. 5A). We could 
never detect any significant difference in the relative 
number of YFP positive cardiomyocytes between sham 
and LAD operated mice especially in the area of the left 
ventricular free wall (Fig. 5B,C). Our data confirm and 
reiterate earlier data shown in neonatal mice [15] and 
recently adult mice [19]; following cardiac injury, 
cardiomyocytes appear to re-enter the cell cycle, 
proliferate, and thereby replace and repair the damaged 
cardiac tissue area. 
 
Changes in cell cycle genes in the postnatal and 
regenerated heart 
 
To assess possible changes in gene expression profiles 
in the heart we first performed RNA-seq at P1, P3, and 
P10 of non-manipulated mice to provide a list of 
Figure 3. A time window for cardiac regeneration. Whole hearts and magnifications at the infarction areas
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comprehensive transcriptional changes of the early 
postnatal heart. Remarkably, we observed changes in 
gene expression of thousands of genes when comparing 
hearts from P1, P3 and P10 after birth (Fig. 6A, Suppl. 
Fig. 1, Supplementary Table 1A-C). We next 
constructed a heat map to determine progression of the 
top 50 differentially expressed genes, in individual 
mice, between P1, P3 and P10 (Fig. 6B). Expression of 
most genes progressed in a near linear fashion from P1 
to P3 and P10 (expression either going up or down 
during this time course), whereas a small number of 
genes robustly showed an increase from P1 to P3 and 
then a decrease from P3 to P10 (or vice versa). The 
most upregulated genes between P1 and P3, all more 
than 10 fold, are: Hrg, Uox, Fabp1, Serpina1C, Pcp4, 







































Among the downregulated genes, NPPA (atrial 
natriuretic factor) is downregulated 9-fold in P1 vs P3 
hearts. Comparing P3 and P10 hearts we found for 
instance marked upregulation of Hemicentin 2, involved 
in the organization of hemidesmosomes [20], or NR4A3, 
a nuclear steroid hormone receptor [21], whereas 
HIF3A and the stem cell/progenitor  marker Nanog 
were ~ 10-fold downregulated in P10 hearts. 
Differential expression of 6 candidate genes was 
confirmed by qRT-PCR (Fig. 6C). Most importantly, 
reactome analyses revealed that the genes changing 
postnatally are almost all mitosis or cytokinesis genes 
(Fig. 6D, Supplementary Table 2). Thus, one key 
transcriptome signature of the postnatal heart is a 
massive change in the mitotic machinery, correlating 














































area of  infarction  (marked by X).  (C) Whole hearts  and magnifications  are  shown  for hearts  LAD‐ligated on P0.5  and
harvested on P7.5. Sections were stained using H&E and immunoflourescently labeled for TroponinT, DAPI, and BrdU as a














































We next compared the cardiac transcriptome of non-
manipulated, LAD-ligated, and sham-operated mice in 
10 day-old mice (P10). Of note LAD ligation or sham-
operations were performed at P1, i.e., we analyzed a 
time-point where we already observed complete 
regeneration of the damaged cardiac tissue. Intriguingly, 
whereas there were large differences in the 
transcriptomes as compared to non-manipulated mice, 
remarkably we detected only a very small number of 
differentially expressed genes (294 genes) at P10 
comparing LAD-ligated and sham-operated mice 
(Fig. 7A,B; Supplementary Table 1D-F). The genes 











































differentially expressed genes are listed in 
Supplementary Table 3. Comparison of the 294 
transcripts that showed statistically significant 
differential expression between LAD and sham-
operated mice showed that most genes were related to 
cell cycle or mitosis, but also included genes on the 
extracellular matrix and collagen synthesis pathways 
(Fig. 7C and Supplementary Table 2). Thus, as 
compared to sham-operations, the regenerated LAD-
ligated hearts show remarkably few transcriptional 
changes, but still carry a gene expression signature 
indicating that the cell cycle machinery has not been 
entirely switched off yet in the repaired cardiac tissue. 
 
Figure  5.  Fate  mapping  of  cardiomyocytes  that  repair  heart  attacks.  (A)  Schematic
representation  of  the  lineage  tracing  experiment.  Homozygous  female  Rosa26‐loxPSTOPloxP‐YFP
reporter mice were crossed with male Myh6‐MerCreMer mice. Tamoxifen (20mg/kg in peanut oil) was
administered  intraperitoneally  into  pregnant  females  at  E19.5. Newborns were  transferred  to  foster
mothers immediately after birth. LAD ligation was performed on P1.5 and hearts were harvested 7 days




















































Efficient heart regeneration has been one of the prime 
visions for cardiology [22, 23]. First attempts to use 
bone marrow derived-progenitor cells have proven 
inconsistent [24, 25] and recently new avenues have 
been taken to identify novel cardiac progenitor 
















































progenitors for heart regeneration [27]. Moreover, it has 
been recently reported that fibroblasts in the damaged 
myocardium can be reprogrammed into cardiomyocytes 
[7, 8] and regeneration can be initiated by pre-existing 
cardiomyocytes [19]. However, in most cases 
regeneration has proven to be limited in terms of the 
repaired areas and in terms of restoration of heart 



























































The discovery that fish can regenerate the heart 
following resection of the tip of the heart was a 
revelation because it introduced the concepts that 
complete heart regeneration might be possible [9]. That 
cardiac regeneration following apex resection is also 
possible in newborn mouse heart [15] further supported 
this notion. Our data now show that newborn mice have 
also the capacity to completely repair, within 7 days, a 
complex injury following a severe cardiac ischemic 
insult. Lineage tracing suggests that, at least in part, 













































pre-existing cardiomyocytes. Based on our gene 
expression data it appears that neonatal cardiomyocytes 
maintain the capacity to proliferate whereas this 
capacity is lost around 7 days after birth. Whether this 
loss correlates and is possibly regulated via binucleation 
of cardiomyocytes, which in mouse occurs within the 
first week after birth [29], needs to be determined.  
 
Intriguingly, although we showed that expression of 
thousands of genes comparing the neonatal heart to 
cardiac tissue on postpartum days 3 and 10, we found 
Figure  7. Differentially  expressed  genes  between  sham‐operated  and  LAD‐ligated mice  left  ventricles.  (A)
Venn diagram of differentially expressed genes  in  the  left ventricle of non‐manipulated, LAD‐ligated and  sham‐operated
mice, all from P10. The numbers of genes differentially expressed comparing non‐manipulated P10 vs LAD‐ligated hearts,
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only about 290 differentially expressed genes between 
sham-operated and LAD ligated hearts assessed on P10. 
As defined by reactome analyses, most of these 
differentially expressed genes have been annotated to 
cell cycle progression, mitosis, or DNA replication. 
Thus, clearly one of the key mechanisms that permit 
regeneration vs scarring is the differential regulation of 
cell cycle genes in the newborn heart. The observation 
of only a small number of differentially expressed genes 
between LAD-ligated and sham-operated mice is 
consistent with the near complete functional recovery of 
cardiac function in LAD-ligated mice. The finding of 
differentially expressed genes on the pathway for 
extracellular matrix and collagen synthesis between 
LAD-ligated and sham-operated mice is likely 
indicative of residual healing of the myocardium post-
infarction. The control of cell cycle progression in 
cardiomyocytes is of particular interest not only for 
cardiac regeneration but also for the fact, that – to our 
knowledge – not a single cardiomyocyte-derived tumor 
has ever been reported in the literature. We of course 
cannot exclude differences in the newborn versus day 7 
old mice in cardiac stem cells, inflammatory responses 
to the tissue damage, or changes in the fibrotic response 
as also playing a part in the alteration in mitotic 
potential of the myocardium between postpartum day 1 
and day 7. 
 
In conclusion, our model system reveals that complete 
repair of a myocardial infarction is possible in the 
newborn mouse. Whether this extends to other 
mammalian species needs to be tested. Importantly, our 
model might allow to possibly unlock fundamental 
mechanisms of regeneration that could be used in the 




Ligation of the left anterior descending artery (LAD) in 
neonates. P0.5, P1.0, P1.5 neonatal and one week old 
(P7.5) C57BL6J mice were used for the LAD ligation 
model. First, neonates were briefly sedated by putting 
the newborns into an isoflurane induction chamber 
followed by an approximately 4 min long cooling 
period in ice water. Hypothermia induces a reversible 
cardiac arrest in pre-weanling rodents and thereby 
allows for controlled thoracic surgery [16]. Next the 
experimental animals were taped to a cooling bag in the 
right lateral position to ensure continued hypothermic 
anesthesia during the surgical procedure. The skin was 
cut just a few millimeters below the left foreleg. Next, 
the Pectorals major et minor muscles were dissected and 
the thorax opened in the 4th intercostal space. Ligation 
of the left anterior descending artery was performed 
with a 10-0 ethilon suture (Ethicon). The 
musculosceletal thorax and the skin were closed with a 
8-0 vicryl suture (Ethicon). Finally, mice were put onto 
a 38o Celsius heated pad. After confirmation of 
spontaneous breathing the mice received a dose of 
subcutaneous buprenorphine (0.05mg/kg). Survival 
rates in our protocol were above 90% of sham-operated 
and above 90% of LAD-ligated mice. All animal 
experiments were approved by the Austrian Ethical 
Board.  
 
Histology. The hearts were harvested at defined time 
points, washed in PBS and then fixed in 4% 
paraformaldehyde (PFA) overnight at room 
temperature. Next, the PFA was exchanged with 70% 
Ethanol and the samples embedded in paraffin and 
cut at 2.5μm. Paraffin sections were rehydrated and 
then either stained with hematoxylin and eosin (HE) 
or further processed for immunohistochemical 
stainings.  
 
Immunohistochemistry. 2.5μm paraffin sections were 
rehydrated followed by antigen retrieval in boiling 
citrate buffer for 20 min. Samples were then stained 
overnight at 4o Celsius with antibodies against phospho-
Histone 3 (Ser10, #04-1093, Millipore), TroponinT 
(#MS-295, Thermo Scientific), BrdU (#ab6326, 
Abcam), cleaved Caspase 3 (#9661, Cell Signaling), 
and Ki67 (#PA0118, Novocastra). Goat anti-mouse 
Alexa 555 and goat anti-rabbit Alexa 488 were used as 
secondary antibodies at room temperature for 1 hr. 
Samples were counterstained with DAPI for 15 min and 
mounted in DAKO. Yellow fluorescent protein (YFP) 
was detected on cryosections; hearts were first fixed in 
4% PFA overnight and then washed in PBS once. Next, 
the fixed hearts were stored in 30% sucrose/PBS at 4o 
Celsius overnight and then embedded in OCT. 10μm 
sections were cut from the cryo-preserved tissue blocks 
and stained with an antibody against GFP that 
crossreacts with YFP (Invitrogen).  
 
Lineage tracing. Homozygous female YFP reporter 
mice (Rosa26-loxP STOP loxP-YFP) were crossed with 
male Myh6-MerCreMer mice. Pregnant females were 
injected Tamoxifen (Sigma, 20mg/kg dissolved in 
peanut oil) intraperitoneally on day E19.5. Newborn 
mice were immediately transferred to a foster mother 
and the LAD ligation procedure was performed on P1.5. 
After 7 days of permanent LAD ligation, hearts were 
harvested on P8.5 and stained for YFP as described 
above. 
 
5-bromo-2-deoxyuridine (BrdU) labeling. LAD ligation 
was performed on P0.5. Subsequently, 0.03 ml of a 
20mg/ml BrdU/0.9%NaCl (Sigma) solution was 
injected intraperitoneally on P1.5 and P3.5.  
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Echocardiography. Myocardial contractility was 
determined by transthoracical echocardiography 
using a Vevo 770 system (Visualsonics, Toronto). 
Long-axis 2D-targeted M-mode images of the left 
ventricle were obtained. Fractional shortening (FS) 
was calculated from digital images by using a 
standard formula. 
 
RNA isolation and RNA-seq library preparation. RNA 
was extracted from 2-5mg of left ventricular tissue from 
three P1, P3, P10, sham-operated and LAD-ligated 
animals without pooling, using Trizol (Invitrogen) 
according to manufacturer’s instructions with an 
additional purification step by on-column DNase 
treatment using the RNase-free DNase Kit (Qiagen) to 
ensure elimination of any genomic DNA. The integrity 
and quantity of RNA was determined using a NanoDrop 
1000 spectrophotometer (Thermo Fisher Scientific) and 
Agilent 2100 Bioanalyzer (Agilent Technologies). 4µg 
of total RNA was used to generate RNA-seq libraries 
using TruSeq RNA sample preparation kit (Illumina) 
according to the manufacturer’s instructions. Briefly, 
RNA was purified and fragmented using poly-T oligo-
attached magnetic beads using two rounds of 
purification followed by the first and second cDNA 
strand synthesis. Next, cDNA 3’ ends were adenylated 
and adapters ligated followed by 10 cycles of library 
amplification. Finally, the libraries were size selected 
using AMPue XP Beads (Becmkan Coulter) purified 
and their quality was checked using Agilent 2100 
Bioanalyzer. Libraries were run on a single lane per 
sample of the HiSeq 2000 platform (Illumina) to 
generate 100bp paired-end reads. 
RT-qPCR. Six differentially expressed genes between 
the pairwise comparisons were selected for validation 
by RT-qPCR: Col12a1, Ddc, Hmgcs2, Spp1, Zbed6 and 
Zbtb20 and for one housekeeping gene, Actb. cDNA 
was synthesized using iScript cDNA synthesis kit 
(BioRad) using manufacturers instruction. Primers were 
designed using Primer 3. Standard curves and 
fluorescent quantitation PCR were performed using 
7900HT Fast Real Time PCR Machine (Applied 
Biosystems) and cDNA quantified according to the 
manufacturer's software.  
 
Differential gene expression analysis. Raw RNASeq 
reads were aligned with Tophat splice junction mapper 
[30], version 1.4.1 against UCSC Human genome 
reference sequence assembly (mm10) and transcript 
annotations (version NCBI 38.68). Gene based read 
counts were then obtained using HTSeq count module 
(version 0.5.3p9). Differential expression analysis was 
performed on the counts data using DESeq 
Bioconductor package [31]. The analysis was run with 
the default parameters. Independent filtering was done 
on the counts data prior to statistical testing to remove 
40 % of the genes with lowest counts. The DESeq 
package uses a negative binomial model to test for 
differential expression. Raw p values were then adjusted 
for multiple testing with the Benjamini-Hochberg 
procedure. Genes with adjusted p value of 0.05 or less 
were termed as differentially expressed genes. The 
analysis was performed using R 2.15. Comparisons 
were performed between non-manipulated P1, P3 and 
P10 mouse hearts. LAD-ligated mouse hearts were 
compared against sham-operated mice samples and also 
against non-manipulated P10 mouse hearts. Of note, 
from the 294 differentially expressed genes comparing 
LAD-ligated vs sham-operated hearts we removed Xist 
from the list in Supplementary Table 3 because of 
current experiments performed to assess sex differences 
between the cohorts.  
 
Clustering analysis. After detecting differentially 
expressed genes in the heart, genes that changed in 
common between all three time points (P1, P3, P10 of 
non-manipulated mice) were then determined using sdef 
R package [32]. The mean of the p values for the 
differentially expressed genes in the three comparisons 
was taken and the top 50 genes with lowest mean p 
value were clustered and visualized in a heatmap. 
Ensembl identifiers were mapped to gene symbols prior 
to produce the heatmap. Custom scripts were written to 
perform the clustering and visualization of the data. The 
analysis was performed using R/2.14.2. 
 
Reactome pathway analysis. Reactome pathway 
analysis was carried out on the genes found to be 
differentially expressed in various comparisons to test 
for enrichment of pathways in the Reactome database. 
The Bioconductor package GOseq [33] was used for 
this enrichment analysis. The package corrects for 
length bias present in RNASeq data. Raw p values were 
adjusted for multiple testing using the Benjamini-
Hochberg procedure. The analysis was performed on R 
2.15. 
 
Statistical analysis of data. All data are expressed as 
mean ± SEM. Statistical analyses were performed using 
the Mann-Whitney U Test (SPSS software). Probability 
values <0.05 were considered significant. P values for 
gene expression differences were adjusted with the 
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Supplementary Figure 1. MA plots showing the distribution of gene expression plotted against log(fold change)
for each gene in each pair wise comparison of P1, P3 and P10. All expression data are from the left ventricle. Red
dots indicate differentially expressed genes (Padj < 0.05), black dots indicate non‐differentially expressed genes. 
.  
